36^th European Neurology Congress

Yuri Danilov, PhD, currently is the Leading Scientist in Pavlov Institute of Physiology, RAS, Sankt Petersburg, Russia. He is a former Senior Scientist and Neuroscience Director in Tactile Communication and Neuromodulation Laboratory (TCNL), Biomedical Engineering Department, UW-Madison, USA. Dr. Danilov received an MS degree in Biophysics, in 1978, from St. Petersburg University in Russia and a Ph.D. degree in neuroscience, in 1984, from the Pavlov Institute of Physiology. He is a system Neuroscientist with experience in research on the special senses, including vision, taste, hearing and balance. Dr. Danilov is the lead discoverer and developer of the Translingual Neurostimulation technology.

Biomedical Engineering, Translingual Neurostimulation

Horacio Kaufmann is Professor of Neurology, Medicine and Pediatrics and holds the Axelrod Chair for Neurological Research at New York University School of Medicine where he also heads the division of Autonomic Disorders and the Dysautonomia Center at NYU Langone Health. Dr. Kaufmann received his medical degree from the National University of Buenos Aires, Argentina. He trained in Internal Medicine and completed Neurology residency and fellowship at Mount Sinai School of Medicine in New York City. His research focuses on the autonomic nervous system and its abnormalities in neurological disorders. Dr. Kaufmann’s research is funded by the National Institute of Health (NIH, NINDS), the US Food and Drug Administration (FDA), the Michael J Fox Foundation, the MSA Coalition and the Dysautonomia Foundation, Inc.

Neurology, Autonomic Disorders, Neurodegenerative disorders, Parkinson's disease

Ivan V. Maksimovich, MD, PhD, professor, who at the present time is an Academician of the Russian Academy of Medical and Technical Sciences, is a member of the Russian Association of Cardiovascular Surgeons, the Russian Scientific Society of Specialists in Endovascular Diagnosis and Treatment, the All-Russian Scientific Society of Interventional Radiologists and Endovascular Surgeons, the Alzheimer's Association International Society for Advance Alzheimer's Research and Treatment (ISTAART), European Society of Cardiology (ESC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), World Stroke Organization (WSO), European Stroke Organization (ESO) and European Psychiatric Association (EPA). Ivan V. Maksimovich graduated from the 1st Moscow Medical Institute named after I.M. Sechenov (Moscow, Russia) in 1979 specializing in cardiovascular surgery. After the graduation he worked in leading research institutes and clinics of the country. Since 1993, Dr. Maksimovich Is the Head of the Clinic of Cardiovascular Diseases named after Most Holy John Tobolsky Moscow, Russia. In 2004, Dr. Maksimovich defended his PhD thesis for the degree of Doctor of Medical Sciences on the subject: "Transluminal Laser Angioplasty in the Treatment of Ischemic Brain Leasons". He is the author of more than 250 scientific papers devoted to transcatheter treatment of vascular diseases.

Brain, Dementia, Alzheimer's disease, Binswanger's Disease

Amin Hajitou completed his PhD at The University of Liege, Belgium, where he acquired extensive experience in delivery technologies for therapeutic nucleic acids. Then he did his postdoctoral training in the world leading MD-Anderson Cancer Center in Texas-USA, where he gained expertise in bacteriophage (phage)-guided gene delivery and phage display technologies in vitro and in vivo. Importantly, he designed a novel hybrid phage vector for targeted nucleic acid transfer to cancer. The hybrid phage, published in Cell 2006, showed first success of systemic gene targeting to cancer in vivo. His team and independent groups reported efficacy of intravenous cancer gene therapy in rodents and pet dogs with naturally occurring cancers. In 2008, Hajitou established his research team, as a Lecturer, at Imperial College, then became Senior Lecturer in 2013 and Reader in 2016. His research team has become a leading authority in phage-guided delivery systems to cancer including brain tumours. His leadership in the field has resulted in various awards for his research, and a Royal Decoration by his Majesty the King of Morocco, in 2015.

Brain tumours, Gene delivery, Bacteriophage vector

Richard K Burt is a Professor of Medicine at Northwestern University Feinberg School of Medicine. He endeavored for 35 years, first with animal models then with some of the world’s first clinical trials, to bring the field of stem cell and cellular therapy to the patient’s bedside. Burt has published 140 mostly first author articles and is the Editor of three medical textbooks. He was the first Autoimmune Committee Chairperson for the International Bone Marrow Transplant Registry (IBMTR) and was the principal investigator of a National Institute of Health (NIH) $10,000,000.00 multi-center contract to develop stem cell clinical trials for autoimmune diseases. Professor Burt performed America’s first hematopoietic stem cell transplant (HSCT) for multiple sclerosis (MS), systemic lupus erythematosus (SLE), Crohn’s disease (CD), stiff person syndrome (SPS), and chronic inflammatory demyelinating polyneuropathy (CIDP) and published the world’s first randomized clinical stem cell transplantation trials for systemic sclerosis and multiple sclerosis. He has been awarded Leukemia Scholar of America, the Lupus Foundation of America Fidelitas Award, the Van Bekkum Award by the European Society for Blood and Marrow Transplantation, and the Distinguished Clinical Achievement Award by the Clinical Research Forum.

Stem Cell, Autoimmune diseases

Ara Garabed Kaprelyan graduated from Higher Medical Institute of Varna in 1988. He is a Specialist in Neurology and Health Management, PhD since 2005, and Professor since 2013. Recently, he is a Chief of First Clinic of Neurology, member of Advisory Council (Neurology division) at University Multiprofi le Hospital for Active Treatment “Sveta Marina", Varna. He is an expert in MS, PD, AD, epilepsy, and chronic pain at National Health Insurance Fund and Republican Consultant of Ministry of Health for North-East region of Bulgaria. He is Head of Department of Neurologic Diseases and Neurosciences at Varna Medical University. His Postgraduate education includes specialization in neuro-oncology, clinical immunology, otoneurology, clinical epileptology, and movement disorders. He has over 150 scientifi c publications and authorship in eight medical text-books and monographs. He is a Member of Bulgarian Society of Neurology (Board of Managers; Chairman of regional branch at Varna district), Bulgarian Association of Neuro-oncology (Vice-president), International Medical Association Bulgaria, Balkan Medical Union (Vice-president of Bulgarian branch), and EAN (scientifi c panels of neuroepidemiology and neuro-oncology). He is in the Editorial Board of Journal of IMAB and Bulgarian Neurology, as well as a Correspondent member of Bulgarian Academy of Sciences and Arts.

Neurology, Neuro-oncology, Clinical Immunology, Movement disorders

Ivan Milanov, DSC graduated medicine in Sofia in 1981 and after that acquired specialty in Neurology. He specialized in movement disorders in the University of Kansas in the United States and in headache at the University of Pavia, Italy. Presently he is a Professor in neurology, National consultant of Ministry of Health in Neurology and consultant to the NHIF (National Health Insurance Fond), Corresponding Member of the Bulgarian Academy of Sciences, Board member and treasurer of the European Society of headache (EHS), Representative of Bulgaria on the board of the World Federation of Neurology (WFN), a member of the New York Academy of Sciences (NYAS) and the International Association for the Study of Pain (IASP - USA). Presently he is the CEO of University Hospital “St. Naum”. He was a Vice-Rector of the Medical University in Sofia from 2004 to 2008 and Deputy Minister of the Ministry of Health in 2010.

Clinical practice, Movement disorders, Multiple sclerosis, Pain, Headache, Clinical electromyography

Jonathan Quinonez passionate about medical cannabis research and advancing this important field of study – which is what attracted me to CannaMD. I look forward to participating in studies and helping patients by providing education, empathy, and evidence-based medical marijuana recommendations.

Hepatotoxicity

Birendra Kumar Bista is one of the first neurologists of Nepal. He has been pioneering in field of neuroscience in Nepal and established the first neuroscience center of eastern Nepal. Through years the work of this neuroscience center has been recognized home and abroad. He shows keen interest in medical management and providing state of art services to this impoverished region of Nepal. Recently he added the first stroke center of Nepal. He firmly believes in continuous updated education and its implementation in hospital practices.

Neurology, Stroke, Blood pressure

Ann Ali Abdelkader Hanafy has completed her MD at the age of 30 years from Cairo University and postdoctoral studies from Cairo University School of Medicine. She is a Professor of Clinical neurophysiology & the President of Egyptian Clinical Neurophysiology Society. She has published more than 100 papers in local and international journals.

Brain stimulation, Central nervous system, Ischemic, Hemorrhagic